Rhea Behlmann is currently a Laboratory Director at Invitae. Her operational expertise includes assay validation, product support, process improvement, client communication, and ensuring regulatory compliance for molecular genetics diagnostic assays. Case reporting includes sequencing and structural variant interpretation & reporting for exome, panel sequencing for both diagnostic and carrier purposes, non-invasive prenatal screening (NIPS), and chromosomal microarray. Prior to joining Invitae, Dr. Behlmann served as a clinical laboratory director at PerkinElmer Genomics and EGL Genetic Diagnostics. She brings with her over 10 years of experience in the clinical diagnostics field from multiple laboratory perspectives, including as a clinical laboratory scientist, validation assay development specialist, and clinical laboratory director. She has co-authored several publications as part of the American College of Medical Genetics (ACMG) Laboratory Quality Assurance committee, as well as research articles and clinical case studies. Dr. Behlmann completed her ABMGG clinical training from Emory University in Atlanta, GA, and earned her doctoral degree in Genetics from Washington University in St. Louis, MO